October 27, 2016 10:34 PM ET

Healthcare Providers and Services

Company Overview of Joslin Diabetes Center, Inc.

Company Overview

Joslin Diabetes Center, Inc. operates as a diabetes research center in the United States. It specializes in diabetes treatment and research; and develops and disseminates patient therapies and scientific discoveries worldwide. The company was founded in 1898 and is headquartered in Boston, Massachusetts.

One Joslin Place

Boston, MA 02215

United States

Founded in 1898





Key Executives for Joslin Diabetes Center, Inc.

Chief Executive Officer and President
Chief Financial Officer, Chief Operating Officer and Treasurer
Age: 58
Chief Scientific Officer, Senior Vice President and Trustee
Chief Academic Officer
Senior Vice President of Medical Affairs
Compensation as of Fiscal Year 2016.

Joslin Diabetes Center, Inc. Key Developments

Joslin Diabetes Center Announces Extended Collaboration with Sanofi for the Development of Novel Treatments for Diabetes Complications

Joslin Diabetes Center announced a newly signed collaboration with Sanofi which extends their ongoing collaboration in exploring novel targets for treatment of diabetes. The parties will direct joint efforts on research and development of new therapeutic options for the treatment of diabetic nephropathy, and explore implications of diabetes on cardiovascular disease.

Joslin Diabetes Center Appoints John A Perry as Chief Development Officer

Joslin Diabetes Center has appointed John A. Perry, CFRE, a skilled fundraising professional with extensive experience in healthcare philanthropy, as Chief Development Officer effective February 1, 2016. Mr. Perry's three decades of fundraising experience includes 15 years within the medical and healthcare sectors. His previous appointment was at Brown University's Warren Alpert Medical School, where he was Senior Associate Dean for Medical Advancement, serving as the Chief Advancement Officer in charge of philanthropy, stewardship, and alumni and parent relations for the medical school.

Joslin Diabetes Center Appoints Peter Amenta as New President and CEO, Effective Oct. 5, 2015 in Replace of John Brooks

Joslin Diabetes Center announced a new president and CEO, a week after seeking and getting the resignation its previous CEO of five years. Dr. Peter Amenta has been appointed to the position, effective Oct. 5, 2015. The move effectively comes from within; in addition to serving as dean of the Rutgers Robert Wood Johnson Medical School for eight years, Amenta sat on the Joslin board of trustees for five years. Amenta left the board of trustees earlier 2015 to take on a consultant role and advisor. The move comes exactly a week after John Brooks III resigned from the position. Brooks also had been promoted to the CEO role in 2011 from a member of the organization's board of directors. He reportedly was asked to resign last week, a move that came unexpectedly. Amenta has also worked at University Hospital of New Jersey and was former CEO of the Robert Wood Johnson Medical Group.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1125 Sir Francis Drake Boulevard Operating Company, Llc United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Joslin Diabetes Center, Inc., please visit www.joslin.org. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.